Download presentation
Presentation is loading. Please wait.
Published byLester O’Neal’ Modified over 9 years ago
1
This article and any supplementary material should be cited as follows: Nitz JC, Perrier J, Cook P. In-vivo trial results of a novel ultrasonic cough stimulator. J Rehabil Res Dev. 2012;49(9):1421–30. http://dx.doi.org/10.1682/JRRD.2011.07.0121 Slideshow Project DOI:10.1682/JRRD.2011.07.0121JSP In-vivo trial results of a novel ultrasonic cough stimulator Jennifer C. Nitz, PhD, MPhty, BPhty; John Perrier, BPhty; Peter Cook, MBBS, FANZCA, FCICM
2
This article and any supplementary material should be cited as follows: Nitz JC, Perrier J, Cook P. In-vivo trial results of a novel ultrasonic cough stimulator. J Rehabil Res Dev. 2012;49(9):1421–30. http://dx.doi.org/10.1682/JRRD.2011.07.0121 Slideshow Project DOI:10.1682/JRRD.2011.07.0121JSP Aim – Establish: Whether ultrasound (US) stimulation can safely stimulate cough. Most efficient US frequency. Whether single- or dual-sided stimulation is more effective. Relevance – Ability to cough voluntarily is absent or diminished in many clinical situations, which may predispose patients to or prolong respiratory diseases.
3
This article and any supplementary material should be cited as follows: Nitz JC, Perrier J, Cook P. In-vivo trial results of a novel ultrasonic cough stimulator. J Rehabil Res Dev. 2012;49(9):1421–30. http://dx.doi.org/10.1682/JRRD.2011.07.0121 Slideshow Project DOI:10.1682/JRRD.2011.07.0121JSP Method Applied stimulation with CoughStim device to 15 nondisabled and 7 unable-to-cough volunteers: – Unilaterally: 8 frequencies and 2 power levels. – Bilaterally: 2 frequencies and 3 power levels.
4
This article and any supplementary material should be cited as follows: Nitz JC, Perrier J, Cook P. In-vivo trial results of a novel ultrasonic cough stimulator. J Rehabil Res Dev. 2012;49(9):1421–30. http://dx.doi.org/10.1682/JRRD.2011.07.0121 Slideshow Project DOI:10.1682/JRRD.2011.07.0121JSP Results Nondisabled subjects – Cough stimulated: 80% at 0.58 MHz and 9 W unilaterally. 75% at 0.58 MHz and 6 W bilaterally Unable-to-cough subjects – Cough stimulated: 71% at 0.54 MHz and 6 W bilaterally.
5
This article and any supplementary material should be cited as follows: Nitz JC, Perrier J, Cook P. In-vivo trial results of a novel ultrasonic cough stimulator. J Rehabil Res Dev. 2012;49(9):1421–30. http://dx.doi.org/10.1682/JRRD.2011.07.0121 Slideshow Project DOI:10.1682/JRRD.2011.07.0121JSP Conclusion CoughStim device: – Regularly and safely produced moderately strong cough response in subjects with or without ability to cough. – Produced this effect without causing undue discomfort.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.